Literature DB >> 27647924

ACOX2 deficiency: A disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment.

Sílvia Vilarinho1, Sinan Sari2, Francesca Mazzacuva3, Kaya Bilgüvar4, Güldal Esendagli-Yilmaz5, Dhanpat Jain6, Gülen Akyol5, Buket Dalgiç2, Murat Günel7, Peter T Clayton3, Richard P Lifton8.   

Abstract

Acyl CoA Oxidase 2 (ACOX2) encodes branched-chain acyl-CoA oxidase, a peroxisomal enzyme believed to be involved in the metabolism of branched-chain fatty acids and bile acid intermediates. Deficiency of this enzyme has not been described previously. We report an 8-y-old male with intermittently elevated transaminase levels, liver fibrosis, mild ataxia, and cognitive impairment. Exome sequencing revealed a previously unidentified homozygous premature termination mutation (p.Y69*) in ACOX2 Immunohistochemistry confirmed the absence of ACOX2 expression in the patient's liver, and biochemical analysis showed marked elevation of intermediate bile acids upstream of ACOX2. These findings define a potentially treatable inborn error of bile acid biosynthesis caused by ACOX2 deficiency.

Entities:  

Keywords:  bile acid metabolism; branched-chain acyl-CoA oxidase; idiopathic liver disease; peroxisomal disorder; whole-exome sequencing

Mesh:

Substances:

Year:  2016        PMID: 27647924      PMCID: PMC5056113          DOI: 10.1073/pnas.1613228113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy.

Authors:  S Ferdinandusse; S Denis; P T Clayton; A Graham; J E Rees; J T Allen; B N McLean; A Y Brown; P Vreken; H R Waterham; R J Wanders
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

2.  Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies.

Authors:  Chengliang Dong; Peng Wei; Xueqiu Jian; Richard Gibbs; Eric Boerwinkle; Kai Wang; Xiaoming Liu
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

3.  Mutations in TJP2 cause progressive cholestatic liver disease.

Authors:  Melissa Sambrotta; Sandra Strautnieks; Efterpi Papouli; Peter Rushton; Barnaby E Clark; David A Parry; Clare V Logan; Lucy J Newbury; Binita M Kamath; Simon Ling; Tassos Grammatikopoulos; Bart E Wagner; John C Magee; Ronald J Sokol; Giorgina Mieli-Vergani; Joshua D Smith; Colin A Johnson; Patricia McClean; Michael A Simpson; A S Knisely; Laura N Bull; Richard J Thompson
Journal:  Nat Genet       Date:  2014-03-09       Impact factor: 38.330

Review 4.  Disorders of bile acid synthesis.

Authors:  Peter Theodore Clayton
Journal:  J Inherit Metab Dis       Date:  2011-01-13       Impact factor: 4.982

5.  Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy.

Authors:  Emmanuel Gonzales; Marie F Gerhardt; Monique Fabre; Kenneth D R Setchell; Anne Davit-Spraul; Isabelle Vincent; James E Heubi; Olivier Bernard; Emmanuel Jacquemin
Journal:  Gastroenterology       Date:  2009-07-19       Impact factor: 22.682

6.  The CoA esters of 2-methyl-branched chain fatty acids and of the bile acid intermediates di- and trihydroxycoprostanic acids are oxidized by one single peroxisomal branched chain acyl-CoA oxidase in human liver and kidney.

Authors:  G F Vanhove; P P Van Veldhoven; M Fransen; S Denis; H J Eyssen; R J Wanders; G P Mannaerts
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

7.  Paediatric hepatocellular carcinoma due to somatic CTNNB1 and NFE2L2 mutations in the setting of inherited bi-allelic ABCB11 mutations.

Authors:  Sílvia Vilarinho; E Zeynep Erson-Omay; Akdes Serin Harmanci; Raffaella Morotti; Geneive Carrion-Grant; Jacob Baranoski; A S Knisely; Udeme Ekong; Sukru Emre; Katsuhito Yasuno; Kaya Bilguvar; Murat Günel
Journal:  J Hepatol       Date:  2014-07-10       Impact factor: 25.083

8.  A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3.

Authors:  Sacha Ferdinandusse; Gerardo Jimenez-Sanchez; Janet Koster; Simone Denis; Carlo W Van Roermund; Irma Silva-Zolezzi; Ann B Moser; Wouter F Visser; Mine Gulluoglu; Ozlem Durmaz; Mubeccel Demirkol; Hans R Waterham; Gülden Gökcay; Ronald J A Wanders; David Valle
Journal:  Hum Mol Genet       Date:  2014-08-28       Impact factor: 6.150

9.  Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome.

Authors:  Mathieu Lemaire; Véronique Frémeaux-Bacchi; Franz Schaefer; Murim Choi; Wai Ho Tang; Moglie Le Quintrec; Fadi Fakhouri; Sophie Taque; François Nobili; Frank Martinez; Weizhen Ji; John D Overton; Shrikant M Mane; Gudrun Nürnberg; Janine Altmüller; Holger Thiele; Denis Morin; Georges Deschenes; Véronique Baudouin; Brigitte Llanas; Laure Collard; Mohammed A Majid; Eva Simkova; Peter Nürnberg; Nathalie Rioux-Leclerc; Gilbert W Moeckel; Marie Claire Gubler; John Hwa; Chantal Loirat; Richard P Lifton
Journal:  Nat Genet       Date:  2013-03-31       Impact factor: 41.307

10.  Individual exome analysis in diagnosis and management of paediatric liver failure of indeterminate aetiology.

Authors:  Sílvia Vilarinho; Murim Choi; Dhanpat Jain; Ajay Malhotra; Sanjay Kulkarni; Dinesh Pashankar; Uma Phatak; Mohini Patel; Allen Bale; Shrikant Mane; Richard P Lifton; Pramod K Mistry
Journal:  J Hepatol       Date:  2014-07-10       Impact factor: 30.083

View more
  24 in total

1.  ACOX2 deficiency in primary malignant cardiac tumors.

Authors:  Xiangyu Zhou; Hongyan Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-11       Impact factor: 11.205

Review 2.  Exome Sequencing in Clinical Hepatology.

Authors:  Sílvia Vilarinho; Pramod K Mistry
Journal:  Hepatology       Date:  2019-12       Impact factor: 17.425

Review 3.  Fatty Acid Oxidation in Peroxisomes: Enzymology, Metabolic Crosstalk with Other Organelles and Peroxisomal Disorders.

Authors:  Ronald J A Wanders; Frédéric M Vaz; Hans R Waterham; Sacha Ferdinandusse
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  Clinical utility of genomic analysis in adults with idiopathic liver disease.

Authors:  Aaron Hakim; Xuchen Zhang; Angela DeLisle; Elif A Oral; Daniel Dykas; Kaela Drzewiecki; David N Assis; Marina Silveira; Jennifer Batisti; Dhanpat Jain; Allen Bale; Pramod K Mistry; Silvia Vilarinho
Journal:  J Hepatol       Date:  2019-04-15       Impact factor: 25.083

5.  Endocrine pheromones couple fat rationing to dauer diapause through HNF4α nuclear receptors.

Authors:  Cheng Gao; Qi Li; Jialei Yu; Shiwei Li; Qingpo Cui; Xiao Hu; Lifeng Chen; Shaobing O Zhang
Journal:  Sci China Life Sci       Date:  2021-11-05       Impact factor: 10.372

6.  Physiological effects of inactivation and the roles of Elovl3/ELOVL3 in maintaining ocular homeostasis.

Authors:  Amber Wilkerson; Nita Bhat; Hoang Quoc Hai Pham; Seher Yuksel; Igor Butovich
Journal:  FASEB J       Date:  2021-02       Impact factor: 5.834

7.  Charge-tagging liquid chromatography-mass spectrometry methodology targeting oxysterol diastereoisomers.

Authors:  William J Griffiths; Thomas Hearn; Peter J Crick; Jonas Abdel-Khalik; Alison Dickson; Eylan Yutuc; Yuqin Wang
Journal:  Chem Phys Lipids       Date:  2017-04-12       Impact factor: 3.329

8.  Combined effects of FH (E404D) and ACOX2 (R409H) cause metabolic defects in primary cardiac malignant tumor.

Authors:  Xiangyu Zhou; Mengjia Xu; Weijia Zeng; Zhongzhong Chen; Guohui Lu; Yun Gong; Richard H Finnell; Huasheng Xiao; Bin Qiao; Hongyan Wang
Journal:  Cell Death Discov       Date:  2018-07-23

9.  Bupleurum marginatum Wall.ex DC in Liver Fibrosis: Pharmacological Evaluation, Differential Proteomics, and Network Pharmacology.

Authors:  Xiujie Liu; Yu Shi; Yinghui Hu; Ke Luo; Ying Guo; Weiwei Meng; Yulin Deng; Rongji Dai
Journal:  Front Pharmacol       Date:  2018-05-17       Impact factor: 5.810

10.  Loss of Enzymes in the Bile Acid Synthesis Pathway Explains Differences in Bile Composition among Mammals.

Authors:  Virag Sharma; Michael Hiller
Journal:  Genome Biol Evol       Date:  2018-12-01       Impact factor: 3.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.